Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19

Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19

BackgroundPTX3 is an important mediator of inflammation and innate immunity. We aimed at assessing its prognostic value in a large cohort of patients hospitalized with COVID-19.MethodsLevels of PTX3 were measured in 152 patients hospitalized with COVID-19 at San Gerardo Hospital (Monza, Italy) since...

Full description

Bibliographic Details
Main Authors: Giuseppe Lapadula, Roberto Leone, Davide Paolo Bernasconi, Andrea Biondi, Emanuela Rossi, Mariella D’Angiò, Barbara Bottazzi, Laura Rachele Bettini, Ilaria Beretta, Cecilia Garlanda, Maria Grazia Valsecchi, Alberto Mantovani, Paolo Bonfanti
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
COVID - 19
pentraxin 3 (PTX3)
mortality
SARS – CoV – 2
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.933960/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.933960/full

Similar Items